Pfizer Selects Turner & Townsend for Expansion of Its Clinical Research Unit in Belgium - European Medical Journal

Pfizer Selects Turner & Townsend for Expansion of Its Clinical Research Unit in Belgium

2 Mins
General Healthcare
  • Global consultancy Turner & Townsend provides project, cost and commercial management services for two fit outs in Brussels, Belgium
  • First part of the project involved the refurbishment of 578 sq m of office accommodating 60 people and a new subject screening area
  • Turner & Townsend is currently working on a second fit out at Erasme Hospital for Pfizer

Turner & Townsend, the global professional services consultancy, has successfully delivered the first of two fit outs on behalf of Pfizer Clinical Research Unit (CRU) located within a renowned teaching hospital in Belgium.

Pfizer currently undertakes studies on healthy volunteers on two floors of the existing Erasme One-Day Hospital in the Brussels region, Belgium. To increase capacity, Pfizer’s original office and volunteers screening area has been divided into two separate units: one office and screening area outside the hospital for ambulatory visits, and another within the hospital for in-house studies.

The first phase of the Pfizer CAH (Centre Administratif Hospitalier) project at Erasme Hospital involved a 578 sq m office fit out, accommodating 60 people and a subject screening area. This area, which has been fully equipped with bespoke medical equipment and analytical instruments, includes six examination beds, two interview rooms and a laboratory.

Turner & Townsend, which is providing project, cost and commercial management services, is now supporting a second phase of refurbishment. This involves the fit out of approximately 1300 sq m, including change and shower room facilities, six patient bedrooms with ensuites, and a grade 2 full laboratory. The final completion date is June 2017.

The global consultancy has previously worked with Pfizer in Belgium, completing an office renovation in 2015, and has new projects starting in South Africa and the Middle East with the biopharmaceutical company.

Luke Bartolo, Director for Turner & Townsend in the Netherlands, commented
“We are excited to be supporting Pfizer on this challenging project, as a continuation from the work we completed recently in Zaventum.

“Our extensive experience within the pharmaceutical sector in combination with our global reach is recognised by Pfizer and we’re looking forward to building the relationship further.

“The feedback from Erasme is extremely positive and we look forward to working closely together over the course of the second phase of the project.”

Kevin Deveson, Global Operations Manager for Pfizer, added
“Turner & Townsend has drawn upon its experience and expertise into this specialised area of research. The first phase of this demanding fit out has been completed according to plan and we’re extremely pleased with the result.

“We’re now focusing on the second part of the project which we’re confident will be up and running from this summer – a much-needed addition to the Pfizer Clinical Research Unit.”

Notes to Editor

Information on Turner & Townsend
Turner & Townsend is an independent professional services company specialising in programme management, project management, cost management and consulting across the real estate, infrastructure and natural resources sectors.

With 97 offices in 41 countries, we draw on our extensive global and industry experience to manage risk while maximising value and performance during the construction and operation of our clients’ assets.

Media Contact
Rhizome Media
Guy Smith
Email: [email protected] 
Tel: + 44 (0) 20 8004 5984

Turner & Townsend
Katharina Hadamik
Email: [email protected]
Tel: +31 (0) 20 658 0060

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?

Keep your finger on the pulse

Join Now

Elevating the Quality of Healthcare Globally